FDA Delays Rule On Regulating Tobacco Until 2018

Law360, New York (March 20, 2017, 6:42 PM EDT) -- The U.S. Food and Drug Administration on Monday said it’s pushing back the implementation of a rule pertaining to the circumstances under which tobacco products can be regulated as medical products until March 2018, after receiving criticism from pharmaceutical organizations backed by Ropes & Gray LLP and Sidley Austin LLP.

The petition filed by the Medical Information Working Group, the Pharmaceutical Research and Manufacturers of America and the Biotechnology Innovation Organization took issue with how the FDA changed its definition of intended uses of products, namely...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.